GLP-1 Receptor Agonists: A Cardiology Perspective
b'Credits: 0.25\\xa0AMA PRA Category 1 Credits\\u2122, 0.25 ABIM MOC\\xa0or 0.25\\xa0AANP, including 0.25 AANP Pharm Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/novo-glp1-podcast-1 Overview: In this podcast, cardiologist Ty Gluckman will take a deep dive into the cardiology benefits of glucagon like peptide-1 receptor agonists (GLP-1 RA). He will review the clinical trial data which has resulted in GLP-1 RA incorporation into guidelines, which address patients who have both diabetes and atherosclerotic cardiovascular disease. He will present the recent American College of Cardiology guidelines and discuss the perspective of a cardiologist on these agents with emerging significance in cardiovascular risk reduction. Guest: Ty J. Gluckman, MD, FACC, FAHA'